Pfizer posts surprise fourth-quarter profit, but some key products miss on sales
Pfizer PFE-N reported a surprise quarterly profit on Tuesday, helped by cost cuts and higher-than-expected demand for its COVID treatment Paxlovid, but sales of some high profile products fell short of Wall Street estimates. The New York-based drugmaker earned 10 cents per share on an adjusted…
#pfizerpfen #pfizer #albertbourla #ireland #michigan #newjersey #jeffjonas #gabellifunds #ibrance #prevnar